-
New Rule Would Require Breast Density Disclosure
A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
-
Telling Their Stories Through Posters
Survivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
-
Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event
Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
by Kevin McLaughlin
-
Sharing Knowledge, Building Community
The executive editor of Cancer Today previews the new issue.
by Kevin McLaughlin
-
Considering the Term “Cancer Survivor”
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
-
Making Clinical Trials More Inclusive
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
-
The Education of a Patient Advocate
Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
-
Reinforcements for Cancer Research
Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
-
An Uncommon Partnership
Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
Being Candid About Cancer
As a father with an aggressive brain cancer, I've opted against elaborate metaphors and in favor of candid speech when talking about cancer with my children.
by Adam Hayden
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles